News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,275 Results
Type
Article (46427)
Company Profile (300)
Press Release (667548)
Section
Business (210159)
Career Advice (2553)
Deals (36225)
Drug Delivery (102)
Drug Development (83547)
Employer Resources (180)
FDA (16635)
Job Trends (15360)
News (356119)
Policy (34049)
Tag
Academia (2747)
Alliances (52385)
Alzheimer's disease (1287)
Approvals (16554)
Artificial intelligence (156)
Bankruptcy (364)
Best Places to Work (11933)
Biotechnology (209)
Breast cancer (182)
Cancer (1354)
Cardiovascular disease (112)
Career advice (2124)
Cell therapy (287)
Clinical research (66613)
Collaboration (467)
Compensation (245)
COVID-19 (2661)
C-suite (110)
Data (1376)
Diabetes (175)
Diagnostics (6357)
Earnings (85425)
Employer resources (158)
Events (112026)
Executive appointments (367)
FDA (17272)
Funding (423)
Gene therapy (204)
GLP-1 (640)
Government (4596)
Healthcare (19471)
Infectious disease (2752)
Inflammatory bowel disease (116)
Interviews (432)
IPO (16545)
Job creations (3817)
Job search strategy (1804)
Layoffs (431)
Legal (8307)
Lung cancer (195)
Manufacturing (205)
Medical device (13665)
Medtech (13670)
Mergers & acquisitions (19796)
Metabolic disorders (462)
Neuroscience (1617)
NextGen Class of 2024 (6844)
Non-profit (4729)
Northern California (1652)
Obesity (266)
Opinion (210)
Patents (118)
People (58123)
Phase I (20705)
Phase II (29304)
Phase III (21839)
Pipeline (504)
Postmarket research (2720)
Preclinical (8817)
Radiopharmaceuticals (239)
Rare diseases (260)
Real estate (6138)
Regulatory (22590)
Research institute (2462)
Resumes & cover letters (426)
Southern California (1437)
Startups (3735)
United States (14958)
Vaccines (603)
Weight loss (196)
Date
Today (125)
Last 7 days (669)
Last 30 days (2868)
Last 365 days (36179)
2024 (35162)
2023 (40933)
2022 (52114)
2021 (56730)
2020 (55515)
2019 (48397)
2018 (36556)
2017 (33414)
2016 (32996)
2015 (38952)
2014 (32760)
2013 (27898)
2012 (30093)
2011 (30767)
2010 (29050)
Location
Africa (831)
Arizona (200)
Asia (39407)
Australia (6573)
California (3717)
Canada (1413)
China (297)
Colorado (170)
Connecticut (174)
Europe (86722)
Florida (514)
Georgia (138)
Illinois (387)
Indiana (222)
Kansas (99)
Maryland (636)
Massachusetts (2917)
Michigan (169)
Minnesota (295)
New Jersey (1069)
New York (1058)
North Carolina (759)
Northern California (1652)
Ohio (147)
Pennsylvania (904)
South America (1206)
Southern California (1437)
Texas (534)
Utah (108)
Washington State (400)
714,275 Results for "quintilesims quintiles inc merged with ims".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Deals
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.
March 20, 2024
·
2 min read
Deals
Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business
Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) business and more than 350 employees from Enlyte to the creation of a new, stand-alone IME company, Emperion, Inc.
March 5, 2024
·
2 min read
Press Releases
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
November 18, 2024
·
8 min read
Press Releases
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
November 15, 2024
·
13 min read
Press Releases
Astellas to Present VEOZA™ (fezolinetant) Data at IMS World Congress on Menopause
October 10, 2024
·
7 min read
Press Releases
Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021
October 29, 2024
·
4 min read
Press Releases
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-Omics
October 9, 2024
·
3 min read
BioForest
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
Immunome, Inc. today announced that it will present preclinical data for IM-3050, the company’s lead lutetium-177 radioligand therapy (RLT) targeting fibroblast activation protein (FAP).
April 5, 2024
·
5 min read
Deals
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Akari Therapeutics, Plc and Peak Bio Inc. announce a definitive agreement to merge as equals in an all-stock transaction.
March 5, 2024
·
17 min read
1 of 71,428
Next
